Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Collegium Pharmaceutical Q4 2023 Adj EPS $1.58 Beats $0.66 Estimate, Sales $149.75M Beat $147.82M Estimate

Author: Benzinga Newsdesk | February 22, 2024 05:32pm
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $0.66 by 139.39 percent. The company reported quarterly sales of $149.75 million which beat the analyst consensus estimate of $147.82 million by 1.30 percent. This is a 15.53 percent increase over sales of $129.62 million the same period last year.

Posted In: COLL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist